Keywords: Endometrial cancer; insulin-sensitizing agents; metformin; secretagogues; population-based; AMPK; activated protein kinase; ISA; insulin-sensitizing agent; PC; principal component; PCA; principal components analysis; PCOS; polycystic ovary syndrome; TZD;